🌺 The #GTSC2026 Hotel Block Is Now Open! Book your stay at the Fairmont Orchid for $399/night + $20/day resort fee. The group rate will be honored 3 days before & after the event if under 80% occupancy! 📅 Book early to lock in the rate! https://t.co/vpzJhlpu7S

We want to see your best work for #GTSC2026! Submit your...Abstracts, Surgical Movies & Scholarship Nominations today! Deadline: Sept 30 Details here 👉 https://t.co/bAZ2f8J6mH @STS_CTsurgery @ctsnetorg @AISChannel

Submit your work for #GTSC2026! We want your: 📌 Groundbreaking abstracts 🎥 Compelling surgical videos 🎓 Scholarship nominations Help shape next year’s meeting! Deadline: Sept 30 👉 https://t.co/bAZ2f8J6mH @STS_CTsurgery @ctsnetorg @AISChannel

Ready to present your research, share your surgical skills, or apply for a scholarship for #GTSC2026?! You're invited to submit your: 📌 Abstracts 🎥 Surgical Movies 🎓 Scholarship Apps Submit by September 30 👉 https://t.co/bAZ2f8JEcf @STS_CTsurgery @ctsnetorg @AISChannel

@UVA_TCV_Surgery @GlobalTSRA @tssmn submit your abstracts! Might be a little more competitive given location 🏝️🌺

Show your work. Share your skill. Be recognized! Abstracts, Surgical Movies & Scholarship Apps for #GTSC2026 are due September 30! Submit yours today! 🔗 https://t.co/bAZ2f8JEcf @STS_CTsurgery @ctsnetorg @AISChannel

🎧 for 🫁 surgeon’s view of: 📉Checkmate 816 OS in depth review 📉 NeoADAURA preop osimertinib💊 review @tssmn @lcsmchat @GlobalTSRA 🫁🔪🤖

🎙️ Episode 5 of The GTSC Podcast is live! Explore Changes in Early Stage Lung Cancer Treatments with @DennisWigle and @LindaMThoracic. Sponsored by @bmsnews. Listen now on the GTSC Website, Apple or Spotify. https://t.co/4h2O9fHTts

🚨 The #GTSC2026 Submission Portal is NOW OPEN! Ready to present your research, share your video surgical skills, or apply for a scholarship?! Submit by September 30 👉 https://t.co/bAZ2f8JEcf @STS_CTsurgery @ctsnetorg @AISChannel

We're excited to welcome the newest members of the GTSC Executive Committee! Looking forward to the impact your leadership will have on the future of the Club. @ChiFuJeffYang @MassGeneralNews @GooseDocMD @ClevelandClinic @ElliotServaisMD @LaheyHospital

This is a great read. D-FLOT approved for all gastric/GEJ adeno (at least in US), but which subset of patients appear to benefit most? Plus, importance of considering MATTERHORN in context of multiple other negative IO trials. Look forward to more of this on your Substack!

@DrewMoghanaki @ElliotServaisMD @IPScottOh @IP_DOC @AAB_IP @crispinhiley @BrendonStilesMD Not sure what that means but what we do is have an honest discussion with patients about the disease biology & risks of surgery vs CT surveillance. I also tend to also refer to my #radonc colleagues once any growth/solid component but they also recommend usually surveillance

Exploration of weight gain associated with TKIs for driver-positive NSCLC @JTOonline. Highest risk associated with lorlatinib (36%), alectinib (15%), crizotinib (5%), lowest with osimertinib and erlotinib. Important to monitor risk over time, management. https://t.co/TIkye72FBl

Phase III Study of Mediastinal Lymph Node Dissection for Ground Glass Opacity–Dominant Lung Adenocarcinoma. Read the full article.

We’re currently in our patient survivorship panel, hearing from seven extraordinary survivors and caregivers—including Kris Kimball, Lauren Coye, Rosemary Conway, Jen Moran, Emily Venanzi, Larry Bromley, and Bertie Gethers. Their stories of courage and resilience are incredibly

@cpeedell @crispinhiley @LungConsultant @DrewMoghanaki @drjamesgood @_ShankarSiva Or no invasive treatment and close observation only. 17.2% of the LND group had tumors with CTR = 0 (ie pure GGO). There’s a good reason why the NCCN guidelines recommend CT scan follow up only for pure GGO

Resurrecting an @STS_CTsurgery blog post that I wrote during the pandemic: ‘Overcoming Setbacks in Your Life’. https://t.co/AzIDwx9wm4 As CEO Dr. Julie Freischlag @JFreischlag is fond of saying: “Don’t just bounce back, bounce up!”

Another 🔑result we’ve been waiting for as 🫁🔪@tssmn @GenThorSurgClub @STS_CTsurgery @GlobalTSRA @AATSHQ Seems like we should start it as soon as EGFR + noted and continue Postop without interruption. IMO

#DitchtheDisk Important editorial in @annalsthorsurg highlighting the imperative for imaging interoperability

Recently published in #JTCVS Open: Surveying surgeon practices and perspectives on extent of intraoperative nodal evaluation in #NSCLC. @LyndonCWalsh, @maraantonoff et al. Read now: https://t.co/hgV81IbpUS

Curious about highlights from #ASCO25? Join us on June 27 for the latest on NSCLC & SCLC breakthroughs, neoadjuvant immunotherapy, EGFR strategies & more. 🎓 1 CME credit available. 👉 Register: https://t.co/3uRkBH93Jd #ASCO25 #LungCancer #CME #Oncology #LCWEBINARS